Michael L. Meyers, SVP, Chief Medical Officer at Syndax Pharmaceuticals Inc (SNDX), bought 200 shares at $4.79 ($958) on 2018-10-30, disclosed to the SEC on 2018-11-07.
Open-market purchase of $958 SNDX by SVP, Chief Medical Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Clearly above the average filing.
| Filing → |
| SNDX | BUY | 2019-03-22 | $5K | — | Filing → |